Third Harmonic Bio, Inc. Common Stock
THRD
THRD: Third Harmonic Bio Inc is a clinical-stage company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases.. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival.
moreShow THRD Financials
Recent trades of THRD by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by THRD's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Crystalline forms of a selective c-kit kinase inhibitor Sep. 26, 2023
-
Patent Title: Pharmaceutical compositions of a selective c-kit kinase inhibitor and methods for making and using same Sep. 05, 2023
Federal grants, loans, and purchases
Followers on THRD's company Twitter account
Number of mentions of THRD in WallStreetBets Daily Discussion
Recent insights relating to THRD
Recent picks made for THRD stock on CNBC
ETFs with the largest estimated holdings in THRD
Flights by private jets registered to THRD